• Home
  • About
  • All Companies
    • Recent
    • Summary Lists
  • Contact

Kuano

  • July 23, 2021
  • New Biotech Startups

Kuano is aiming to transform the discovery of enzyme inhibitor drugs using a platform that combines quantum transition state simulation and AI led chemistry.

Enzyme catalysis occurs via thermodynamically favoured quantum transition states, which represent an attractive conformation for targeting enzyme inhibitors. Kuano’s proprietary in silico approach rapidly simulates the quantum transition state and generates a quantum pharmacophore. The quantum pharmacophore is used with AI/ML approaches to identify transition state inhibitors in novel chemical space.

According to Kuano, enzyme transition state-based drug discovery has previously been time consuming and costly. As a result, structure-based drug discovery for enzyme inhibitors has focused on an imperfect model of ligand-enzyme interactions. Kuano says its approach rapidly and cost-effectively generates inherently better enzyme inhibitors that provide strong binding, high selectivity and are more robust to mutations.

In addition to in-house discovery programs (in epigenetics, protein degradation, immunometabolism, infectious disease and others) the company is also pursuing drug discovery collaborations with pharmaceutical and biotech companies seeking new approaches to novel, first in class, best in class or next generation inhibitors for validated or intractable enzyme targets.

 


Subscribe for alerts on new companies featured on Startups.Bio


July 22, 2022hC Bioscience
hC Bioscience is developing Transfer RNA-based therapeutics targeting protein dysfunction. Transfer RNA (tRNA) is a small RNA molecule that plays a key role in protein …
July 7, 2022Melius Pharma
Melius Pharma is a Swedish company founded in 2021 focused on the development of new treatments for interstitial lung diseases. The company's lead project for …
June 29, 2022Therorna
Therorna was founded in China in 2021, leveraging its proprietary circular RNA technology platform to develop next-generation vaccines and innovative therapies. Compared with linear RNA, …
June 21, 2022Tamarix Pharma
Tamarix Pharma was founded in 2021 based on technology licensed from the National Institute for Biotechnology in the Negev (Israel) and is focused on developing …
June 15, 2022BacVax
BacVax is a spin-off from the University of Arizona with a novel approach to developing vaccines against bacterial infections by mapping the proteins on the …
June 7, 2022Lento Bio
Lento Bio was founded in 2022 in collaboration with Ichor Life Sciences and Clarkson University’s Shipley Center for Innovation, with the goal to develop effective, …

Tags:

© Copyright 2022. Startups.Bio, powered by VentureRadar.